$TARA announced positive Phase 2 results for TARA-002 in NMIBC, showing a 72% six-month complete response rate, 100% CR in BCG-unresponsive patients

See More Pre-market Movers 👇
www.biopharmcatalyst.com/news/2024/pr...

$BLUE $BRTX $NNOX $RNXT $AFMD $TOVX $QNTM $MESO $NKTX